ElezabyMLiGBhargavan-ChatfieldMBurnsideESDeMartiniWB. ACR BI-RADS assessment category 4 subdivisions in diagnostic mammography: utilization and outcomes in the national mammography database. Radiology. 2018;287(2):416-422.
2.
DuckworthLAHodaRKomfortiMKRoweJJDowns-KellyEMcIntirePJ. Re-classification with outcome correlation of previously diagnosed malignant phyllodes tumors applying the 2016 consensus guidelines. Int J Surg Pathol. 2023;31(5):557-563.
3.
LiYSongYLangR, et al.Retrospective study of malignant phyllodes tumors of the breast: younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence. Breast. 2021;57:62-70.
4.
TanBYAcsGAppleSK, et al.Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5-21.
5.
TanPHEllisIAllisonK, et al.The 2019 world health organization classification of tumours of the breast. Histopathology. 2020;77(2):181-185.
6.
Graadt van RoggenJFZonderlandHMWelvaartKPeterseJLHogendoornPC. Local recurrence of a phyllodes tumour of the breast presenting with widespread differentiation to a telangiectatic osteosarcoma. J Clin Pathol. 1998;51(9):706-708.
7.
MukherjeePKalishLHDelpradoWCreaP. Telangiectatic osteosarcomatous differentiation in a phyllodes tumour. ANZ J Surg. 2004;74(8):707-709.
8.
IiharaKMachinamiRKubotaSItoyamaSSatoA. Malignant cystosarcoma phyllodes tumor of the breast mainly composed of chondrosarcoma: a case report. Gen Diagn Pathol. 1997;142(3-4):241-245.
9.
BarnesLPietruszkaM. Rhabdomyosarcoma arising within a cystosarcoma phyllodes. Case report and review of the literature. Am J Surg Pathol. 1978;2(4):423-429.
